Pithecellobium dulce (Roxb.) Benth. has been used as a folk medicine due to its wide range of pharmacological applications. In light of the lack of significant studies examining the anti-inflammatory potential of seeds and their phytochemical constituents, we investigated the molecular basis behind the therapeutic efficacy of methanolic extract both in-vitro and in-vivo. The phytochemical investigation of methanolic seed extract using GC-MS analysis revealed the presence of 30 molecules of diverse classes. Further solvent fractionation followed by RP-HPLC separation demonstrated the presence of 9-Hexadecenoic acid and 8,11,14 (Z, Z, Z)-Eicosatrienoic acid and were further structurally characterized by 1H-NMR and HRMS. 9-Hexadecenoic acid-rich HPLC fraction exhibited the highest % inhibition of albumin denaturation and % reduction of IL-8 and IL-6 in HaCaT cells as well as NO and PGE-2 production in RAW267.4 cells among other test samples. In-vivo anti-inflammatory findings revealed that 9-Hexadecenoic acid-rich fraction potentially reduced rat paw edema by 84.62% at 150 µg/mL, which is superior to the diclofenac. The results of the present study revealed that the 9-hexadecenoic acid-rich fraction of methanolic seed extract of P. dulce displayed potential anti-inflammatory activity both in-vitro and in-vivo, which suggests an efficient alternative in treating a variety of ailments related to inflammation and pain.
Pithecellobium dulce Methanolic seed extract Anti-inflammatory activity 9-hexadecenoic acid GC-MS HPLC.
Primary Language | English |
---|---|
Subjects | Pharmacology and Pharmaceutical Sciences (Other) |
Journal Section | Articles |
Authors | |
Publication Date | June 28, 2025 |
Published in Issue | Year 2023 Volume: 27 Issue: 5 |